The high cost challenge of personalised screening for bowel cancer

Personalised screening could improve the diagnosis of bowel cancer and re-shape the future of Australia’s National Bowel Cancer Screening Program (NBCSP), according to new research at The University of Western Australia. The study, published today in Cancer Epidemiology, Biomarkers and Prevention, a journal of the American Association for Cancer Research, hopes to improve health outcomes by targeting screening at those […]

Continue reading »

Technology holds personalised cancer vaccine breakthrough

University of Queensland researchers have developed a vaccine delivery technology that enables treatment to be tailored precisely for different cancers. UQ’s Professor Ranjeny Thomas said the technology had the potential to improve the precision of cancer immunotherapy, leading to better cancer outcomes and reduce harmful side-effects. “Flexible cancer vaccines are a long-sought treatment strategy in cancer immunotherapy,” Professor Thomas said. […]

Continue reading »

Scientists develop novel cancer cell culture test kit for personalised, precise cancer therapy

A team of scientists led by Professor Lim Chwee Teck, Principal Investigator at the Mechanobiology Institute, Singapore (MBI) and the Department of Biomedical Engineering at the National University of Singapore (NUS) and NUS Ph.D. graduate Dr. Khoo Bee Luan, has developed a novel and robust cancer cell-based assay that could help clinicians to diagnose cancer, monitor the disease state and […]

Continue reading »